Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-02-01 @ 11:27 AM
Study NCT ID:
NCT02018861
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2013-12-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
Sponsor:
Incyte Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-Cell Malignancies | View |
Keywords: